Take 2) Starpharma's option agreement with AstraZeneca. Is Faslodex the drug???, page-46

Probably for the same reasons everything is taking so long - management


In relation to Viraleze, one wonders why Japan isn't a high priority target for a Medical Device application, especially given the easier regulatory pathways in comparison to many other western countries ... the COVID-19 statistics over there at the moment are a little out of control with an average of 250,000 new COVID-19 cases per day and 275 deaths per day over the last 3 days


https://www.worldometers.info/coronavirus/




Certainly seems like some were busy pumping the stock on the weekend with new thread titles etc